Loading…
Alvotech is projected to rise to $3.57 by 2027, a +4% move from its current price of $3.44. ALVO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $3.33 | $3.44 | $3.55 | 0.00% |
| May 30 | $3.29 | $3.44 | $3.60 | 0.00% |
| May 31 | $3.25 | $3.44 | $3.64 | 0.00% |
| Jun 1 | $3.22 | $3.44 | $3.67 | +0.01% |
| Jun 2 | $3.20 | $3.44 | $3.70 | +0.01% |
| Jun 3 | $3.18 | $3.44 | $3.72 | +0.01% |
| Jun 4 | $3.16 | $3.44 | $3.75 | +0.01% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.16 | $3.44 | $3.75 | +0.01% |
| Week 2 | $3.05 | $3.44 | $3.88 | +0.02% |
| Week 3 | $2.97 | $3.44 | $3.99 | +0.03% |
| Week 4 | $2.90 | $3.44 | $4.08 | +0.04% |
| Week 5 | $2.84 | $3.44 | $4.17 | +0.04% |
| Week 6 | $2.79 | $3.44 | $4.25 | +0.05% |
| Week 7 | $2.74 | $3.44 | $4.32 | +0.06% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Alvotech (ALVO) is a healthcare stock focused on developing and manufacturing biosimilar medicines for patients worldwide. Through its subsidiaries, it offers biosimilar products in autoimmune, eye, and bone disorders, as well as cancer, including AVT02, a high concentration, low-volume adalimumab formulation biosimilar to Humira; AVT04, a biosimilar to Stelara; AVT06, a biosimilar to Eylea; AVT03, a biosimilar to Xgeva and Prolia; AVT05, a biosimilar to Simponi and Simponi Aria; AVT16, a biosimilar to Entyvio; AVT23, a biosimilar to Xolair; and AVT33, a biosimilar to Keytruda that is in early phase development.
ALVO trades as a healthcare stock with a current price of $3.34 and a market capitalization of $1.04B, ranking 2516. The price outlook spans from 2026 through 2050 with year-by-year forecasts that include neutral sentiment in the near term and bullish momentum in the longer term.
A major floor 13.8% below — a decisive break under it would weaken the trend.
The nearest floor, 7.0% below — buyers have tended to step in here.
The nearest ceiling, 6.7% above — a clean break opens room to run.
A major ceiling 57.6% above — clearing it would confirm fresh momentum.
Key ALVO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ALVO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.38 | Buy | $3.39 | Buy |
| MA 10 | $3.38 | Buy | $3.39 | Buy |
| MA 20 | $3.41 | Buy | $3.41 | Buy |
| MA 50 | $3.46 | Sell | $3.59 | Sell |
| MA 100 | $4.04 | Sell | $4.13 | Sell |
| MA 200 | $5.52 | Sell | $5.39 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.12 | Neutral |
| Stoch RSI (14) | 68.19 | Neutral |
| CCI (20) | 21.00 | Neutral |
| Williams %R (14) | -48.94 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 5.52 | Buy |
| Bollinger %B (20,2) | 0.57 | Neutral |
| Stochastic %K (14) | 51.06 | Neutral |
| TRIX (15) | -0.18 | Sell |
| Awesome (5,34) | -0.08 | Sell |
| Ultimate (7,14,28) | 59.63 | Neutral |
| Momentum (10) | -0.11 | Sell |
| Aroon Osc (25) | 16.00 | Buy |
| Hull MA (9) | 3.41 | Buy |
| ADX (14) | 9.07 | Neutral |
| ATR (14) | 0.10 | Info |
Near term, sentiment is BEARISH, with RSI14 at 50. The stock trades around the SMA50 of $3.47 and well below the SMA200 of $5.57. Key technical levels include support at $3.20 and resistance at $3.71. The 30-day range runs from $2.67 to $4.18, indicating notable volatility over the period.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.11 | $3.44 | $4.88 | 0% | Neutral | |
| $2.78 | $3.57 | $4.88 | +4% | Neutral | |
| $2.61 | $3.46 | $4.94 | +1% | Neutral | |
| $2.69 | $3.67 | $5.40 | +7% | Neutral | |
| $2.78 | $3.88 | $5.88 | +13% | Neutral | |
| $3.23 | $4.61 | $7.15 | +34% | Bullish | |
| $3.37 | $4.93 | $7.80 | +43% | Bullish | |
| $3.40 | $5.07 | $8.18 | +47% | Bullish | |
| $3.34 | $5.07 | $8.33 | +47% | Bullish | |
| $3.09 | $4.77 | $7.98 | +39% | Bullish | |
| $3.94 | $6.63 | $11.88 | +93% | Bullish | |
| $7.47 | $14.58 | $28.85 | +324% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $3.11 | $3.44 | $4.06 | +0.00% |
| June 2026 | $2.97 | $3.50 | $4.24 | +1.80% |
| July 2026 | $2.89 | $3.44 | $4.23 | -1.66% |
| August 2026 | $2.94 | $3.53 | $4.39 | +2.48% |
| September 2026 | $3.07 | $3.71 | $4.67 | +5.18% |
| October 2026 | $3.08 | $3.74 | $4.74 | +0.74% |
| November 2026 | $3.03 | $3.70 | $4.73 | -1.00% |
| December 2026 | $3.09 | $3.79 | $4.88 | +2.48% |
Click any year to see its month-by-month ALVO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Alvotech's 2026 outlook centres on $3.44, within a $3.11 to $4.88 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, ALVO could reach as high as $4.88, with a base case around $3.57 and support toward $2.78 — roughly +4% from $3.44. Price action looks broadly range-bound.
Expect ALVO to range from $2.61 to $4.94 through 2028. The $3.46 average target implies a +1% move from current prices. That is -3% versus the projected 2027 average. A consolidation phase looks the most probable path here.
The ALVO price prediction for 2029 points to an average of $3.67 (low $2.69, high $5.40) — a potential gain of +7% on today's $3.44. Price action looks broadly range-bound.
In 2030, ALVO is projected to trade between $2.78 and $5.88, averaging $3.88 — a potential gain of +13% from today's $3.44. That is up +6% on the projected 2029 average. A consolidation phase looks the most probable path here.
Alvotech's 2031 outlook centres on $4.61, within a $3.23 to $7.15 range. That is up +19% on the projected 2030 average. That marks a +34% change versus current levels. Momentum favours further upside here.
By 2032, ALVO could reach as high as $7.80, with a base case around $4.93 and support toward $3.37 — roughly +43% from $3.44. Buyers look set to stay in control over this stretch.
Expect ALVO to range from $3.40 to $8.18 through 2033. The $5.07 average target implies a +47% move from current prices. That is up +3% on the projected 2032 average. Momentum favours further upside here.
The ALVO price prediction for 2034 points to an average of $5.07 (low $3.34, high $8.33) — a potential gain of +47% on today's $3.44. Buyers look set to stay in control over this stretch.
In 2035, ALVO is projected to trade between $3.09 and $7.98, averaging $4.77 — a potential gain of +39% from today's $3.44. That is -6% versus the projected 2034 average. Momentum favours further upside here.
Alvotech's 2040 outlook centres on $6.63, within a $3.94 to $11.88 range. That is up +39% on the projected 2035 average. That marks a +93% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, ALVO could reach as high as $28.85, with a base case around $14.58 and support toward $7.47 — roughly +324% from $3.44. Momentum favours further upside here.
Investing $1,000 in ALVO today (≈ 290.697674 ALVO) could be worth
$4,239.21
+$3,239.21 (+324%) by 2050 · US Dollar
Based on the average projected ALVO price of $14.58 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ALVOwould be worth at today's price.
$1,000 invested in ALVO on May 27, 2025 (≈ 88.261254 ALVO) would be worth
$303.62
-$696.38 (-69.6%) today · 0.30× · US Dollar
Based on a ALVO entry price of $11.33 vs. today's $3.44.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.3 | $1,042.42 | +4.2% |
| 1 month ago | $3.3 | $1,042.42 | +4.2% |
| 3 months ago | $4.16 | $826.92 | -17.3% |
| 6 months ago | $5.1 | $674.51 | -32.5% |
| 1 year ago | $11.33 | $303.62 | -69.6% |
| All time (3.9y) ago | $11.19 | $307.42 | -69.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ALVO forecast.
Our base-case forecast reaches $6.90 around 2050.
Implied market cap at $6.90: $2.15B
Longer horizon forecasts show gradual upside, with 2030 and beyond turning increasingly bullish. The 2030 average price is $3.73 with an ROI of 11.6%. By 2040, the average rises to $6.42 (ROI 92.1%), and by 2050 the average is $14.26 (ROI 327.1%).
Early years (2031–2034) show strong bullish momentum, with average prices around $4.47–$4.90 and ROIs ranging from 33.9% to 46.6%. The forecast also notes a 2050 max of $28.79 and a 2040 max of $11.69, underscoring the potential for substantial upside. Risks include a mixed sentiment path in the near term and high volatility, as reflected by an annualized volatility of 60%.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $3.73 with a max of $5.71 and a min of $2.64, corresponding to an ROI of 11.6% and a neutral sentiment.
The forecast starts neutral in the near term (e.g., 2026–2030) and turns bullish from 2031 onward, with higher average prices and ROIs through 2050 (e.g., 327.1% in 2050).
Yes. The forecast shows a 2040 max of $11.69 and a 2050 max of $28.79, indicating $10 could be reached by 2040 in the higher-price scenario.
Current price is $3.34 and market cap is $1.04B.
The 30-day range is $2.67 to $4.18.
Alvotech Community Discussion
0Share your Alvotech price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.